Lipid peroxidation and renal cell carcinoma: Further supportive evidence and new mechanistic insights

Free Radical Biology and Medicine

Volumn 40, Issue 4, 2006, Pages 721-733

  Gago Dominguez, Manuela ^a   Castelao, J Esteban ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Apoptosis; Free radical; Hypoxia inducible factors; Lipid peroxidation; Oxidative stress; Renal cell cancer; VHL gene

Indexed keywords

ALCOHOL DEHYDROGENASE; ANALGESIC AGENT; ANTILIPEMIC AGENT; ANTIOXIDANT; CATALASE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYTOCHROME P450 2C9; FUMONISIN B1; GLUTATHIONE PEROXIDASE 1; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE P1; GLUTATHIONE TRANSFERASE T1; MANGANESE SUPEROXIDE DISMUTASE; METHYLENETETRAHYDROFOLATE DEHYDROGENASE; NUCLEIC ACID BINDING PROTEIN; ORAL CONTRACEPTIVE AGENT; PROTEIN MISMATCH REPAIR PROTEIN; PROTEIN MISMATCH REPAIR PROTEIN MLH1; PROTEIN MISMATCH REPAIR PROTEIN MLH2; UNCLASSIFIED DRUG; VON HIPPEL LINDAU PROTEIN;

ALCOHOL CONSUMPTION; APOPTOSIS; CANCER GROWTH; CARCINOGENESIS; DIABETES MELLITUS; DRUG METABOLISM; HUMAN; HYPERTENSION; HYSTERECTOMY; KIDNEY CARCINOMA; LIPID PEROXIDATION; NONHUMAN; OBESITY; ORAL CONTRACEPTION; OVARIECTOMY; OXIDATIVE STRESS; PARITY; PREECLAMPSIA; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SMOKING;

EID: 31644443187     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2005.09.026     Document Type: Article

References (175)

1. M. Gago-Dominguez, J.E. Castelao, J.M. Yuan, R.K. Ross, and M.C. Yu Lipid peroxidation: a novel and unifying concept of the etiology of renal cell carcinoma (United States) Cancer Causes Control 13 2002 287 293
2. S. Greenland, M. Gago-Dominguez, and J. Castelao The value of risk-factor ("Black-Box") epidemiology Epidemiology 15 2004 529 535
3. A. Paganini-Hill, A. Chao, R.K. Ross, and B.E. Henderson Aspirin use and chronic diseases: a cohort study of the elderly BMJ 299 1989 1247 1250
4. N.R. Asal, D.R. Risser, S. Kadamani, J.R. Geyer, E.T. Lee, and N. Cherng Risk factors in renal cell carcinoma: I. Methodology, demographics, tobacco, beverage use, and obesity Cancer Detect. Prev. 11 1988 359 377
5. A. Mellemgaard, S. Niwa, E.S. Mehl, G. Engholm, J.K. McLaughlin, and J.H. Olsen Risk factors for renal cell carcinoma in Denmark: role of medication and medical history Int. J. Epidemiol. 23 1994 923 930
6. M. Gago-Dominguez, J.M. Yuan, J.E. Castelao, R.K. Ross, and M.C. Yu Regular use of analgesics is a risk factor for renal cell carcinoma Br. J. Cancer 81 1999 542 548
7. I. Durak, M. Karaayvaz, M.Y. Cimen, A. Avci, O.B. Cimen, S. Buyukkocak, H.S. Ozturk, H. Ozbek, and M. Kacmaz Aspirin impairs antioxidant system and causes peroxidation in human erythrocytes and guinea pig myocardial tissue Hum. Exp. Toxicol. 20 2001 34 37
8. G. Sener-Muratoglu, K. Paskaloglu, S. Arbak, C. Hurdag, and G. Ayanoglu-Dulger Protective effect of famotidine, omeprazole, and melatonin against acetylsalicylic acid-induced gastric damage in rats Dig. Dis. Sci. 46 2001 318 330
9. N. Sugimoto, N. Yoshida, T. Yoshikawa, Y. Nakamuara, H. Ichikawa, Y. Naito, and M. Kondo Effect of vitamin E on aspirin-induced gastric mucosal injury in rats Dig. Dis. Sci. 45 2000 599 605
10. B. Ji, Y. Masubuchi, and T. Horie A possible mechanism of naproxen-induced lipid peroxidation in rat liver microsomes Pharmacol. Toxicol. 89 2001 43 48
11. F.A. Hemieda, M.A. El-Missiry, M.E. Badawy, and A.A. Goda Partial suppressive effect of melatonin on indomethacin-induced renal injury in rat Indian J. Exp. Biol. 42 2004 63 67
12. E.J. Hickey, R.R. Raje, V.E. Reid, S.M. Gross, and S.D. Ray Diclofenac induced in vivo nephrotoxicity may involve oxidative stress-mediated massive genomic DNA fragmentation and apoptotic cell death Free Radic. Biol. Med. 31 2001 139 152
13. G. Engelhardt, and D. Homma Effects of acetylsalicylic acid, paracetamol and caffeine and a combination of these substances on kidney glutathione levels Arzneimittel Forschung 46 1996 513 518
14. G.G. Duggin Mechanisms in the development of analgesic nephropathy Kidney Int. 18 1980 553 561
15. R.J. McMurtry, W.R. Snodgrass, and J.R. Mitchell Renal necrosis, glutathione depletion, and covalent binding after acetaminophen Toxicol. Appl. Pharmacol. 46 1978 87 100
16. M. Enoiu, R. Herber, R. Wennig, C. Marson, H. Bodaud, P. Leroy, N. Mitrea, G. Siest, and M. Wellman Gamma-Glutamyltranspeptidase-dependent metabolism of 4-hydroxynonenal-glutathione conjugate Arch. Biochem. Biophys. 397 2002 18 27
17. A. Wolk, G. Gridley, S. Niwa, P. Lindblad, M. McCredie, A. Mellemgaard, J.S. Mandel, J. Wahrendorf, J.K. McLaughlin, and H.O. Adami International renal cell cancer study. VII. Role of diet Int. J. Cancer 65 1996 67 73
18. A.S. Parker, J.R. Cerhan, C.F. Lynch, A.G. Ershow, and K.P. Cantor Gender, alcohol consumption, and renal cell carcinoma Am. J. Epidemiol. 155 2002 455 462
19. R.J. Prineas, A.R. Folsom, Z.M. Zhang, T.A. Sellers, and J. Potter Nutrition and other risk factors for renal cell carcinoma in postmenopausal women Epidemiology 8 1997 31 36
20. S. Mahabir, M.F. Leitzmann, M.J. Virtanen, J. Virtamo, P. Pietinen, D. Albanes, and P.R. Taylor Prospective study of alcohol drinking and renal cell cancer risk in a cohort of Finnish male smokers Cancer Epidemiol. Biomarkers Prev. 14 2005 170 175
21. M.C. Yu, T.M. Mack, R. Hanisch, C. Cicioni, and B.E. Henderson Cigarette smoking, obesity, diuretic use, and coffee consumption as risk factors for renal cell carcinoma J. Natl. Cancer Inst. 77 1986 351 356
22. R.C. Brownson A case-control study of renal cell carcinoma in relation to occupation, smoking, and alcohol consumption Arch. Environ. Health 43 1988 238 241
23. M. Maclure, and W. Willett A case-control study of diet and risk of renal adenocarcinoma Epidemiology 1 1990 430 440
24. J.K. McLaughlin, Y.T. Gao, R.N. Gao, W. Zheng, B.T. Ji, W.J. Blot, and J.F. Fraumeni Jr. Risk factors for renal-cell cancer in Shanghai, China Int. J. Cancer 52 1992 562 565
25. S. Benhamou, M.H. Lenfant, C. Ory-Paoletti, and R. Flamant Risk factors for renal-cell carcinoma in a French case-control study Int. J. Cancer 55 1993 32 36
26. N. Kreiger, L.D. Marrett, L. Dodds, S. Hilditch, and G.A. Darlington Risk factors for renal cell carcinoma: results of a population-based case-control study Cancer Causes Control 4 1993 101 110
27. W. Schmidt, and J. De Lint Causes of death of alcoholics Q. J. Stud. Alcohol 33 1972 171 185
28. S. Pell, and C.A. D'Alonzo A five-year mortality study of alcoholics J. Occup. Med. 15 1973 120 125
29. R.R. Monson, and J.L. Lyon Proportional mortality among alcoholics Cancer 36 1975 1077 1079
30. O.M. Jensen Cancer morbidity and causes of death among Danish brewery workers Int. J. Cancer 23 1979 454 463
31. H.O. Adami, J.K. McLaughlin, A.W. Hsing, A. Wolk, A. Ekbom, L. Holmberg, and I. Persson Alcoholism and cancer risk: a population-based cohort study Cancer Causes Control 3 1992 419 425
32. Y. Miyagi, K. Miwa, and H. Inoue Inhibition of human low-density lipoprotein oxidation by flavonoids in red wine and grape juice Am. J. Cardiol. 80 1997 1627 1631
33. I. Durak, A. Avci, M. Kacmaz, S. Buyukkocak, M.Y. Cimen, S. Elgun, and H.S. Ozturk Comparison of antioxidant potentials of red wine, white wine, grape juice and alcohol Curr. Med. Res. Opin. 15 1999 316 320
34. I.B. Puddey, K.D. Croft, R. Abdu-Amsha Caccetta, and L.J. Beilin Alcohol, free radicals and antioxidants Novartis Found. Symp. 216 1998 51 62
35. E.N. Frankel, J. Kanner, J.B. German, E. Parks, and J.E. Kinsella Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine Lancet 341 1993 454 457
36. P.H. van Golde, L.M. Sloots, W.P. Vermeulen, J.P. Wielders, H.C. Hart, B.N. Bouma, and A. van de Wiel The role of alcohol in the anti low density lipoprotein oxidation activity of red wine Atherosclerosis 147 1999 365 370
37. S. Maxwell, A. Cruickshank, and G. Thorpe Red wine and antioxidant activity in serum Lancet 344 1994 193 194
38. B. Fuhrman, A. Lavy, and M. Aviram Consumption of red wine with meals reduces the susceptibility of human plasma and low-density lipoprotein to lipid peroxidation Am. J. Clin. Nutr. 61 1995 549 554
39. T.J. Hartman, D.J. Baer, L.B. Graham, W.L. Stone, E.W. Gunter, C.E. Parker, P.S. Albert, J.F. Dorgan, B.A. Clevidence, W.S. Campbell, K.B. Tomer, J.T. Judd, and P.R. Taylor Moderate alcohol consumption and levels of antioxidant vitamins and isoprostanes in postmenopausal women Eur. J. Clin. Nutr. 59 2005 161 168
40. H. Alho, P. Sillanaukee, A. Kalela, O. Jaakkola, S. Laine, and S.T. Nikkari Alcohol misuse increases serum antibodies to oxidized LDL and C-reactive protein Alcohol Alcohol 39 2004 312 315
41. M. Sato, N. Maulik, and D.K. Das Cardioprotection with alcohol: role of both alcohol and polyphenolic antioxidants Ann. N.Y. Acad. Sci. 957 2002 122 135
42. H. Higuchi, I. Kurose, S. Kato, S. Miura, and H. Ishii Ethanol-induced apoptosis and oxidative stress in hepatocytes Alcohol.: Clin. Exp. Res. 20 1996
43. I. Kurose, H. Higuchi, S. Miura, H. Saito, N. Watanabe, R. Hokari, M. Hirokawa, M. Takaishi, S. Zeki, T. Nakamura, H. Ebinuma, S. Kato, and H. Ishii Oxidative stress-mediated apoptosis of hepatocytes exposed to acute ethanol intoxication Hepatology 25 1997 368 378
44. A. Tydings, R.R. Weiss, J.H. Lin, J. Bennett, and N. Tejani Renal-cell carcinoma and mesangiocapillary glomerulonephritis presenting as severe pre-eclampsia N.Y. State J. Med. 78 1978 1950 1954
45. J.J. Morrison, and R.E. Robinson Renal cell carcinoma: an unusual cause of second trimester hypertension Br. J. Obstet. Gynaecol. 99 1992 775 776
46. E. Steiner, G. Devaud, P. Etienne, and P. Colombeau Isolated arterial hypertension during pregnancy disclosing a malignant tumor of the kidney. Apropos of a case [French] J. Chir. (Paris). 121 1984 123 125
47. L.C. Chesley Renal carcinoma and possible renovascular hypertension in a primigravida Obstet. Gynecol. 34 1969 231 234
48. Y. Wang, and S.W. Walsh Placental mitochondria as a source of oxidative stress in pre-eclampsia Placenta 19 1998 581 586
49. M. Ishihara Studies on lipoperoxide of normal pregnant women and of patients with toxemia of pregnancy Clin. Chim. Acta 84 1978 1 9
50. D. Wickens, M.H. Wilkins, J. Lunec, G. Ball, and T.L. Dormandy Free radical oxidation (peroxidation)products in plasma in normal and abnormal pregnancy Ann. Clin. Biochem. 18 1981 158 162
51. Y.P. Wang, S.W. Walsh, J.D. Guo, and J.Y. Zhang The imbalance between thromboxane and prostacyclin in preeclampsia is associated with an imbalance between lipid peroxides and vitamin E in maternal blood Am. J. Obstet. Gynecol. 165 1991 1695 1700
52. C.A. Hubel, M.K. McLaughlin, R.W. Evans, B.A. Hauth, C.J. Sims, and J.M. Roberts Fasting serum triglycerides, free fatty acids, and malondialdehyde are increased in preeclampsia, are positively correlated, and decrease within 48 hours post partum Am. J. Obstet. Gynecol. 174 1996 975 982
53. U. Mutlu-Turkoglu, G. Aykac-Toker, L. Ibrahimoglu, E. Ademoglu, and M. Uysal Plasma nitric oxide metabolites and lipid peroxide levels in preeclamptic pregnant women before and after delivery Gynecol. Obstet. Invest. 48 1999 247 250
54. E. Gratacos, E. Casals, R. Deulofeu, V. Cararach, P.L. Alonso, and A. Fortuny Lipid peroxide and vitamin E patterns in pregnant women with different types of hypertension in pregnancy Am. J. Obstet. Gynecol. 178 1998 1072 1076
55. A. Barden, L.J. Beilin, J. Ritchie, K.D. Croft, B.N. Walters, and C.A. Michael Plasma and urinary 8-iso-prostane as an indicator of lipid peroxidation in pre-eclampsia and normal pregnancy Clin. Sci. 91 1996 711 718
56. I.D. Alexa, L. Jerca, and V. Gheorghita The role of lipid peroxidation and of the antioxidant systems in normal pregnancy and in pre-eclampsia Revista Medico Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 100 1996 84 89
57. S.W. Walsh, and Y. Wang Deficient glutathione peroxidase activity in preeclampsia is associated with increased placental production of thromboxane and lipid peroxides Am. J. Obstet. Gynecol. 169 1993 1456 1461
58. Y. Wang, S.W. Walsh, and H.H. Kay Placental lipid peroxides and thromboxane are increased and prostacyclin is decreased in women with preeclampsia Am. J. Obstet. Gynecol. 167 1992 946 949
59. A.C. Staff, T. Ranheim, J. Khoury, and T. Henriksen Increased contents of phospholipids, cholesterol, and lipid peroxides in decidua basalis in women with preeclampsia Am. J. Obstet. Gynecol. 180 1999 587 592
60. A.C. Staff, B. Halvorsen, T. Ranheim, and T. Henriksen Elevated level of free 8-iso-prostaglandin F2alpha in the decidua basalis of women with preeclampsia Am. J. Obstet. Gynecol. 181 1999 1211 1215
61. S.W. Walsh, J.E. Vaughan, Y. Wang, and L.J. Roberts II Placental isoprostane is significantly increased in preeclampsia FASEB J. 14 2000 1289 1296
62. S.W. Walsh, and Y. Wang Trophoblast and placental villous core production of lipid peroxides, thromboxane, and prostacyclin in preeclampsia J. Clin. Endocrinol. Metab. 80 1995 1888 1893
63. P. Lindblad, A. Mellemgaard, B. Schlehofer, H.O. Adami, M. McCredie, J.K. McLaughlin, and J.S. Mandel International renal-cell cancer study: V. Reproductive factors, gynecologic operations and exogenous hormones Int. J. Cancer 61 1995 192 198
64. E. Arteaga, A. Rojas, P. Villaseca, and M. Bianchi The effect of 17beta-estradiol and alpha-tocopherol on the oxidation of LDL cholesterol from postmenopausal women and the minor effect of gamma-tocopherol and melatonin Menopause 7 2000 112 116
65. T. Miura, S. Muraoka, and Y. Fujimoto Effect of estrogens on the oxidative damage induced by ferrylmyoglobin J. Steroid Biochem. Mol. Biol. 67 1998 57 62
66. S. Ayres, W. Abplanalp, J.H. Liu, and M.T. Subbiah Mechanisms involved in the protective effect of estradiol-17beta on lipid peroxidation and DNA damage Am. J. Physiol. 274 1998 E1002 E1008
67. S.A. Lund, J. Murdoch, E.A. Van Kirk, and W.J. Murdoch Mitogenic and antioxidant mechanisms of estradiol action in preovulatory ovine follicles: relevance to luteal function Biol. Reprod. 61 1999 388 392
68. M. Liu, and S. Okada Induction of free radicals and tumors in the kidneys of Wistar rats by ferric ethylenediamine-N,N′-diacetate Carcinogenesis 15 1994 2817 2821
69. Y. Kurokawa, Y. Matsushima, N. Takamura, T. Imazawa, and Y. Hayashi Relationship between the duration of treatment and the incidence of renal cell tumors in male F344 rats administered potassium bromate Japanese Journal of Cancer Research 78 1987 358 364
70. Y. Kurokawa, A. Maekawa, M. Takahashi, and Y. Hayashi Toxicity and carcinogenicity of potassium bromate-A new renal carcinogen Environ. Health Perspect. 87 1990 309 335
71. H.K. Bhat, G. Calaf, T.K. Hei, T. Loya, and J.V. Vadgama Critical role of oxidative stress in estrogen-induced carcinogenesis Proc. Natl. Acad. Sci. USA 100 2003 3913 3918
72. M.Y. Wang, and J.G. Liehr Induction by estrogens of lipid peroxidation and lipid peroxide-derived malonaldehyde-DNA adducts in male Syrian hamsters: role of lipid peroxidation in estrogen-induced kidney carcinogenesis Carcinogenesis 16 1995 1941 1945
73. A.D. Rahimtula, J.C. Bereziat, V. Bussacchini-Griot, and H. Bartsch Lipid peroxidation as a possible cause of ochratoxin A toxicity Biochem. Pharmacol. 37 1988 4469 4477
74. R.F. Omar, A.D. Rahimtula, and H. Bartsch Role of cytochrome P-450 in ochratoxin A-stimulated lipid peroxidation J. Biochem. Toxicol. 6 1991 203 209
75. T. Kuiper-Goodman, and P.M. Scott Risk assessment of the mycotoxin ochratoxin A Biomed. Environ. Sci. 2 1989 179 248
76. J.C. Gautier, D. Holzhaeuser, J. Markovic, E. Gremaud, B. Schilter, and R.J. Turesky Oxidative damage and stress response from ochratoxin a exposure in rats Free Radic. Biol. Med. 30 2001 1089 1098
77. S. Hashimoto Study on the effects of the hypocholesteremic agents, cholestyramine and compactin on the induction of renal tumors in rats by N-ethyl-N-hydroxyethyl nitrosamine [Japanese] Nippon Hinyokika Gakkai Zasshi Japanese Journal of Urology 83 1992 75 84
78. X. Qin, S. Zhang, M. Zarkovic, Y. Yamazaki, H. Oda, Y. Nakatsuru, and T. Ishikawa Inhibitory effect of probucol on nephrotoxicity induced by ferric nitrilotriacetate (Fe-NTA) in rats Carcinogenesis 16 1995 2549 2552
79. R. Salonen, K. Nyssonen, E. Porkkala-Sarataho, and J.T. Salonen The Kuopio Atherosclerosis Prevention Study (KAPS): effect of pravastatin treatment on lipids, oxidation resistance of lipoproteins, and atherosclerotic progression Am. J. Cardiol. 76 1995 28
80. J. Girona, A.E. La Ville, R. Sola, N. Plana, and L. Masana Simvastatin decreases aldehyde production derived from lipoprotein oxidation Am. J. Cardiol. 83 1999 846 851
81. M.R. Graaf, A.B. Beiderbeck, A.C.G. Egberts, D.J. Richel, and H.-J. Guchelaar The risk of cancer in users of statins Proc. Am. Soc. Clin. Oncol. 39th Annual Meeting 22 2003 846 (Chicago, May 31-June 3, 2003)
82. M. Elisaf, and D.P. Mikhailidis Statins and renal function Angiology 53 2002 493 502
83. J.M. McKenney Potential nontraditional applications of statins Ann. Pharmacother. 37 2003 1063 1071
84. J.M. van den Akker, S.J. Bredie, S.H. Diepenveen, L.J. van Tits, A.F. Stalenhoef, and R. van Leusen Atorvastatin and simvastatin in patients on hemodialysis: effects on lipoproteins, C-reactive protein and in vivo oxidized LDL J. Nephrol. 16 2003 238 244
85. J.H. Stewart, G. Buccianti, L. Agodoa, R. Gellert, M.R. McCredie, A.B. Lowenfels, A.P. Disney, R.A. Wolfe, P. Boyle, and P. Maisonneuve Cancers of the kidney and urinary tract in patients on dialysis for end-stage renal disease: analysis of data from the United States, Europe, and Australia and New Zealand J. Am. Soc. Nephrol. 14 2003 197 207
86. D. Zhang, S. Okada, Y. Yu, P. Zheng, R. Yamaguchi, and H. Kasai Vitamin E inhibits apoptosis, DNA modification, and cancer incidence induced by iron-mediated peroxidation in Wistar rat kidney Cancer Res. 57 1997 2410 2414
87. S. Ansar, M. Iqbal, and M. Athar Nordihydroguairetic acid is a potent inhibitor of ferric-nitrilotriacetate-mediated hepatic and renal toxicity, and renal tumour promotion, in mice Carcinogenesis 20 1999 599 606
88. T. Kimoto, S. Koya, K. Hino, Y. Yamamoto, Y. Nomura, M.J. Micallef, T. Hanaya, S. Arai, M. Ikeda, and M. Kurimoto Renal carcinogenesis induced by ferric nitrilotriacetate in mice, and protection from it by Brazilian propolis and artepillin C Pathol. Int. 50 2000 679 689
89. V.Z. Lankin, N.I. Sherenesheva, G.G. Konovalova, and A.K. Tikhaze Beta-carotene-containing preparation carinat inhibits lipid peroxidation and development of renal tumors in rats treated with chemical carcinogen Bull. Exp. Biol. Med. 130 2000 694 706
90. S. Okada, Y. Fukunaga, S. Hamazaki, Y. Yamada, and S. Toyokuni Sex differences in the localization and severity of ferric nitrilotriacetate-induced lipid peroxidation in the mouse kidney Acta Pathol. Jpn. 41 1991 221 226
91. K. Sai, C.A. Tyson, D.W. Thomas, J.E. Dabbs, R. Hasegawa, and Y. Kurokawa Oxidative DNA damage induced by potassium bromate in isolated rat renal proximal tubules and renal nuclei Cancer Lett. 87 1994 1 7
92. B.B. Hasinoff, A.D. Rahimtula, and R.F. Omar NADPH-cytochrome-P-450 reductase promoted hydroxyl radical production by the iron(III)-ochratoxin A complex Biochim. Biophys. Acta 1 1990 78 81
93. R.I. Salganik The benefits and hazards of antioxidants: controlling apoptosis and other protective mechanisms in cancer patients and the human population J. Am. Coll. Nutr. 20 2001 473S 475S
94. D.M. Hockenbery, Z.N. Oltvai, X.M. Yin, C.L. Milliman, and S.J. Korsmeyer Bcl-2 functions in an antioxidant pathway to prevent apoptosis Cell 75 1993 241 251
95. J.F. Kalinich, R. Ramakrishnan, D.E. McClain, and N. Ramakrishnan 4-Hydroxynonenal, an end-product of lipid peroxidation, induces apoptosis in human leukemic T- and B-cell lines Free Radic. Res. 33 2000 349 358
96. P.C. Howard, A. Warbritton, K.A. Voss, R.J. Lorentzen, J.D. Thurman, R.M. Kovach, and T.J. Bucci Compensatory regeneration as a mechanism for renal tubule carcinogenesis of fumonisin B1 in the F344/N/Nctr BR rat Environ. Health Perspect. 2 2001 309 314
97. J. Chandra, A. Samali, and S. Orrenius Triggering and modulation of apoptosis by oxidative stress Free Radic. Biol. Med. 29 2000 323 333
98. M.J. Gonzalez, R.A. Schemmel, J.I. Gray, L. Dugan Jr., L.G. Sheffield, and C.W. Welsch Effect of dietary fat on growth of MCF-7 and MDA-MB231 human breast carcinomas in athymic nude mice: relationship between carcinoma growth and lipid peroxidation product levels Carcinogenesis 12 1991 1231 1235
99. M.J. Gonzalez, R.A. Schemmel, L. Dugan Jr., J.I. Gray, and C.W. Welsch Dietary fish oil inhibits human breast carcinoma growth: a function of increased lipid peroxidation Lipids 28 1993 827 832
100. C.W. Welsch Review of the effects of dietary fat on experimental mammary gland tumorigenesis: role of lipid peroxidation Free Radic. Biol. Med. 18 1995 757 773
101. V. Chajes, W. Sattler, A. Stranzl, and G.M. Kostner Influence of n-3 fatty acids on the growth of human breast cancer cells in vitro: relationship to peroxides and vitamin-E Breast Cancer Res. Treat. 34 1995 199 212
102. Gago-Dominguez, M.; Castelao, J.; Pike, M. C.; Sevanian, A.; Haile, R. W. The role of lipid peroxidation in the epidemiology and prevention of breast cancer. Cancer Epidemiol. Biomarkers Prev.; in press.
103. P.C. Howard, R.M. Eppley, M.E. Stack, A. Warbritton, K.A. Voss, R.J. Lorentzen, R.M. Kovach, and T.J. Bucci Fumonisin b1 carcinogenicity in a two-year feeding study using F344 rats and B6C3F1 mice Environ. Health Perspect. 2 2001 277 282
104. (NTP) N. T. P. Technical Report on the Toxicology and the Carcinogenesis Studies of Fumonisin B1 in F344/N Rats and B6C3F1 mice, 2001.
105. 1, in rats Carcinogenesis 12 1991 1247 1251
106. W.H. Tolleson, K.L. Dooley, W.G. Sheldon, J.D. Thurman, T.J. Bucci, and P.C. Howard The mycotoxin fumonisin induces apoptosis in cultured human cells and in livers and kidneys of rats Adv. Exp. Med. Biol. 392 1996 237 250
107. S.M. Cohen Cell proliferation and carcinogenesis Drug Metabolism Reviews 30 1998 339 357
108. Y.P. Dragan, W.R. Bidlack, S.M. Cohen, T.L. Goldsworthy, G.C. Hard, P.C. Howard, R.T. Riley, and K.A. Voss Implications of apoptosis for toxicity, carcinogenicity, and risk assessment: fumonisin B(1) as an example Toxicol. Sci. 61 2001 6 17
109. A.G. Knudson Jr. Mutation and cancer: statistical study of retinoblastoma Proc. Natl. Acad. Sci. USA 68 1971 820 823
110. S.M. Cohen, and L.B. Ellwein Cell proliferation in carcinogenesis Science 249 1990 1007 1011
111. S.M. Cohen, and L.B. Ellwein Genetic errors, cell proliferation, and carcinogenesis Cancer Res. 51 1991 6493 6505
112. S.H. Moolgavkar, and A.G. Knudson Mutation and cancer: a model for human carcinogenesis J. Natl. Cancer Inst. 66 1981 1037 1052
113. U. Das A radical approach to cancer Medical Science Monitor 8 2002 RA79 RA92
114. R.A. Kirkland, J.A. Windelborn, J.M. Kasprzak, and J.L. Franklin A Bax-induced pro-oxidant state is critical for cytochrome c release during programmed neuronal death J. Neurosci. 22 2002 6480 6490
115. T.W. Young, F.C. Mei, G. Yang, J.A. Thompson-Lanza, J. Liu, and X. Cheng Activation of antioxidant pathways in ras-mediated oncogenic transformation of human surface ovarian epithelial cells revealed by functional proteomics and mass spectrometry Cancer Res. 64 2004 4577 4584
116. R.L. Ward, A.V. Todd, F. Santiago, T. O'Connor, and N.J. Hawkins Activation of the K-ras oncogene in colorectal neoplasms is associated with decreased apoptosis Cancer 79 1997 1106 1113
117. D.L. Uhlman, P.L. Nguyen, J.C. Manivel, D. Aeppli, J.M. Resnick, E.E. Fraley, G. Zhang, and G.A. Niehans Association of immunohistochemical staining for p53 with metastatic progression and poor survival in patients with renal cell carcinoma J. Natl. Cancer Inst. 86 1994 1470 1475
118. T. Uchida, J.P. Gao, C. Wang, S.X. Jiang, M. Muramoto, T. Satoh, S. Minei, S. Shimura, A. Irie, T. Kameya, and S. Baba Clinical significance of p53, mdm2, and bcl-2 proteins in renal cell carcinoma Urology 59 2002 615 620
119. H. Shiina, M. Igawa, S. Urakami, H. Shirakawa, T. Ishibe, and M. Kawanishi Clinical significance of immunohistochemically detectable p53 protein in renal cell carcinoma Eur. Urol. 31 1997 73 80
120. W.G. Kaelin, O. Iliopoulos, K.M. Lonergan, and M. Ohh Functions of the von Hippel-Lindau tumour suppressor protein J. Intern. Med. 243 1998 535 539
121. M. Gago-Dominguez, J.M. Yuan, J.E. Castelao, R.K. Ross, and M.C. Yu Family history and risk of renal cell carcinoma Cancer Epidemiol. Biomarkers Prev. 10 2001 1001 1004
122. O. Iliopoulos, A. Kibel, S. Gray, and W.G. Kaelin Jr. Tumour suppression by the human von Hippel-Lindau gene product Nat. Med. 1 1995 822 826
123. A. Schoenfeld, E.J. Davidowitz, and R.D. Burk A second major native von Hippel-Lindau gene product, initiated from an internal translation start site, functions as a tumor suppressor Proc. Natl. Acad. Sci. USA 95 1998 8817 8822
124. P. Devarajan, M. De Leon, F. Talasazan, A.R. Schoenfeld, E.J. Davidowitz, and R.D. Burk The von Hippel-Lindau gene product inhibits renal cell apoptosis via Bcl-2-dependent pathways J. Biol. Chem. 276 2001 40599 40605
125. A.R. Schoenfeld, T. Parris, A. Eisenberger, E.J. Davidowitz, M. De Leon, F. Talasazan, P. Devarajan, and R.D. Burk The von Hippel-Lindau tumor suppressor gene protects cells from UV-mediated apoptosis Oncogene 19 2000 5851 5857
126. M. Gorospe, J.M. Egan, B. Zbar, M. Lerman, L. Geil, I. Kuzmin, and N.J. Holbrook Protective function of von Hippel-Lindau protein against impaired protein processing in renal carcinoma cells Mol. Cell. Biol. 19 1999 1289 1300
127. W.G. Kaelin Jr., and E.R. Maher The VHL tumour-suppressor gene paradigm Trends Genet. 14 1998 423 426
128. O. Iliopoulos, A.P. Levy, C. Jiang, W.G. Kaelin Jr., and M.A. Goldberg Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein Proc. Natl. Acad. Sci. USA 93 1996 10595 10599
129. T. Kamura, S. Sato, K. Iwai, M. Czyzyk-Krzeska, R.C. Conaway, and J.W. Conaway Activation of HIF1alpha ubiquitination by a reconstituted von Hippel-Lindau (VHL) tumor suppressor complex Proc. Natl. Acad. Sci. USA 97 2000 10430 10435
130. M.E. Cockman, N. Masson, D.R. Mole, P. Jaakkola, G.W. Chang, S.C. Clifford, E.R. Maher, C.W. Pugh, P.J. Ratcliffe, and P.H. Maxwell Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein J. Biol. Chem. 275 2000 25733 25741
131. D. Mukhopadhyay, B. Knebelmann, H.T. Cohen, S. Ananth, and V.P. Sukhatme The von Hippel-Lindau tumor suppressor gene product interacts with Sp1 to repress vascular endothelial growth factor promoter activity Mol. Cell. Biol. 17 1997 5629 5639
132. M. Krieg, R. Haas, H. Brauch, T. Acker, I. Flamme, and K.H. Plate Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function Oncogene 19 2000 5435 5443
133. P.H. Maxwell, M.S. Wiesener, G.W. Chang, S.C. Clifford, E.C. Vaux, M.E. Cockman, C.C. Wykoff, C.W. Pugh, E.R. Maher, and P.J. Ratcliffe The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis Nature 399 1999 271 275
134. J.R. Gnarra, S. Zhou, M.J. Merrill, J.R. Wagner, A. Krumm, E. Papavassiliou, E.H. Oldfield, R.D. Klausner, and W.M. Linehan Post-transcriptional regulation of vascular endothelial growth factor mRNA by the product of the VHL tumor suppressor gene Proc. Natl. Acad. Sci. USA 93 1996 10589 10594
135. G. Siemeister, K. Weindel, K. Mohrs, B. Barleon, G. Martiny-Baron, and D. Marme Reversion of deregulated expression of vascular endothelial growth factor in human renal carcinoma cells by von Hippel-Lindau tumor suppressor protein Cancer Res. 56 1996 2299 2301
136. S.K. Sarada, P. Dipti, B. Anju, T. Pauline, A.K. Kain, M. Sairam, S.K. Sharma, G. Ilavazhagan, D. Kumar, and W. Selvamurthy Antioxidant effect of beta-carotene on hypoxia induced oxidative stress in male albino rats J. Ethnopharmacol. 79 2002 149 153
137. L.R. Feldenberg, S. Thevananther, M. del Rio, M. de Leon, and P. Devarajan Partial ATP depletion induces Fas- and caspase-mediated apoptosis in MDCK cells Am. J. Physiol. 276 1999
138. S.P. Ayalasomayajula, and U.B. Kompella Induction of vascular endothelial growth factor by 4-hydroxynonenal and its prevention by glutathione precursors in retinal pigment epithelial cells Eur. J. Pharmacol. 449 2002 213 220
139. J. Ruef, Z.Y. Hu, L.Y. Yin, Y. Wu, S.R. Hanson, A.B. Kelly, L.A. Harker, G.N. Rao, M.S. Runge, and C. Patterson Induction of vascular endothelial growth factor in balloon-injured baboon arteries. A novel role for reactive oxygen species in atherosclerosis Circ. Res. 81 1997 24 33
140. J.W. Slaton, K. Inoue, P. Perrotte, A.K. El-Naggar, D.A. Swanson, I.J. Fidler, and C.P. Dinney Expression levels of genes that regulate metastasis and angiogenesis correlate with advanced pathological stage of renal cell carcinoma Am. J. Pathol. 158 2001 735 743
141. L.F. Brown, B. Berse, R.W. Jackman, K. Tognazzi, E.J. Manseau, H.F. Dvorak, and D.R. Senger Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas Am. J. Pathol. 143 1993 1255 1262
142. A. Takahashi, H. Sasaki, S.J. Kim, K. Tobisu, T. Kakizoe, T. Tsukamoto, Y. Kumamoto, T. Sugimura, and M. Terada Markedly increased amounts of messenger RNAs for vascular endothelial growth factor and placenta growth factor in renal cell carcinoma associated with angiogenesis Cancer Res. 54 1994 4233 4237
143. C. Dosquet, M.C. Coudert, E. Lepage, J. Cabane, and F. Richard Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma? Clin. Cancer Res. 3 1997 2451 2458
144. J. Jacobsen, T. Rasmuson, K. Grankvist, and B. Ljungberg Vascular endothelial growth factor as prognostic factor in renal cell carcinoma J. Urol. 163 2000 343 347
145. G.M. Li The role of mismatch repair in DNA damage-induced apoptosis Oncol. Res. 11 1999 393 400
146. A. Bellacosa Functional interactions and signaling properties of mammalian DNA mismatch repair proteins Cell Death Differ. 8 2001 1076 1092
147. R.A. Hardman, C.A. Afshari, and J.C. Barrett Involvement of mammalian MLH1 in the apoptotic response to peroxide-induced oxidative stress Cancer Res. 61 2001 1392 1397
148. T.L. DeWeese, J.M. Shipman, N.A. Larrier, N.M. Buckley, L.R. Kidd, J.D. Groopman, R.G. Cutler, H. te Riele, and W.G. Nelson Mouse embryonic stem cells carrying one or two defective Msh2 alleles respond abnormally to oxidative stress inflicted by low-level radiation Proc. Natl. Acad. Sci. USA 95 1998 11915 11920
149. F.S. Leach, M. Koh, K. Sharma, G. McWilliams, L. Talifero-Smith, A. Codd, R. Olea, and O. Elbahloul Mismatch repair gene mutations in renal cell carcinoma Cancer Biol. Ther. 1 2002 530 536
150. E. Rohrdanz, and R. Kahl Alterations of antioxidant enzyme expression in response to hydrogen peroxide Free Rad. Biol. Med. 24 1998 27 38
151. Y. Shao, L. Pardini, and R.S. Pardini Dietary menhaden oil enhances mitomycin C antitumor activity toward human mammary carcinoma MX-1 Lipids 30 1995 1035 1045
152. J.R. Wispe, J.C. Clark, M.S. Burhans, K.E. Kropp, T.R. Korfhagen, and J.A. Whitsett Synthesis and processing of the precursor for human mangano-superoxide dismutase Biochim. Biophys. Acta 994 1989 30 36
153. S. Shimoda-Matsubayashi, H. Matsumine, T. Kobayashi, Y. Nakagawa-Hattori, Y. Shimizu, and Y. Mizuno Structural dimorphism in the mitochondrial targeting sequence in the human manganese superoxide dismutase gene. A predictive evidence for conformational change to influence mitochondrial transport and a study of allelic association in Parkinson's disease Biochem. Biophys. Res. Commun. 226 1996 561 565
154. S.L. Church, J.W. Grant, E.U. Meese, and J.M. Trent Sublocalization of the gene encoding manganese superoxide dismutase (MnSOD/SOD2) to 6q25 by fluorescence in situ hybridization and somatic cell hybrid mapping Genomics 14 1992 823 825
155. X.S. Wan, M.N. Devalaraja, and D.K. St Clair Molecular structure and organization of the human manganese superoxide dismutase gene DNA Cell Biol. 13 1994 1127 1136
156. Y. Huang, J. Peng, L.W. Oberley, and F.E. Domann Transcriptional inhibition of manganese superoxide dismutase (SOD2) gene expression by DNA methylation of the 5′ CpG island Free Radic. Biol. Med. 23 1997 314 320
157. C.A. Harris, K.S. Derbin, B. Hunte-McDonough, M.R. Krauss, K.T. Chen, D.M. Smith, and L.B. Epstein Manganese superoxide dismutase is induced by IFN-gamma in multiple cell types. Synergistic induction by IFN-gamma and tumor necrosis factor or IL-1 J. Immunol. 147 1991 149 154
158. P. Huang, L. Feng, E.A. Oldham, M.J. Keating, and W. Plunkett Superoxide dismutase as a target for the selective killing of cancer cells Nature 407 2000 390 395
159. S. Kuninaka, Y. Ichinose, K. Koja, and Y. Toh Suppression of manganese superoxide dismutase augments sensitivity to radiation, hyperthermia and doxorubicin in colon cancer cell lines by inducing apoptosis Br. J. Cancer 83 2000 928 934
160. C. Sarto, C. Deon, G. Doro, D.F. Hochstrasser, P. Mocarelli, and J.C. Sanchez Contribution of proteomics to the molecular analysis of renal cell carcinoma with an emphasis on manganese superoxide dismutase Proteomics 1 2001 1288 1294
161. T.D. Oberley, J.M. Sempf, M.J. Oberley, M.L. McCormick, K.E. Muse, and L.W. Oberley Immunogold analysis of antioxidant enzymes in human renal cell carcinoma Virchows Archiv. 424 1994 155 164
162. C. Sarto, S. Frutiger, F. Cappellano, J.C. Sanchez, G. Doro, F. Catanzaro, G.J. Hughes, D.F. Hochstrasser, and P. Mocarelli Modified expression of plasma glutathione peroxidase and manganese superoxide dismutase in human renal cell carcinoma Electrophoresis 20 1999 3458 3466
163. T. Shi, F. Dong, L.S. Liou, Z.H. Duan, A.C. Novick, and J.A. DiDonato Differential protein profiling in renal-cell carcinoma Mol. Carcinog. 40 2004 47 61
164. F. Ursini, M. Maiorino, and C. Gregolin Phospholipid hydroperoxide glutathione peroxidase Int. J. Tissue React. 8 1986 99 103
165. J.B. de Haan, C. Bladier, P. Griffiths, M. Kelner, R.D. O'Shea, N.S. Cheung, R.T. Bronson, M.J. Silvestro, S. Wild, S.S. Zheng, P.M. Beart, P.J. Hertzog, and I. Kola Mice with a homozygous null mutation for the most abundant glutathione peroxidase, Gpx1, show increased susceptibility to the oxidative stress-inducing agents paraquat and hydrogen peroxide J. Biol. Chem. 273 1998 22528 22536
166. M.E. Begin, G. Ells, and D.F. Horrobin Polyunsaturated fatty acid-induced cytotoxicity against tumor cells and its relationship to lipid peroxidation J. Natl. Cancer Inst. 80 1988 188 194
167. N. Avissar, D.B. Ornt, Y. Yagil, S. Horowitz, R.H. Watkins, E.A. Kerl, K. Takahashi, I.S. Palmer, and H.J. Cohen Human kidney proximal tubules are the main source of plasma glutathione peroxidase Am. J. Physiol. 266 1994.
168. I. Durak, Y. Beduk, M. Kavutcu, S. Ozturk, O. Canbolat, and S. Ulutepe Activities of superoxide dismutase and glutathione peroxidase enzymes in cancerous and non-cancerous human kidney tissues Int. Urol. Nephrol. 29 1997 5 11
169. D.R. Spitz, J.H. Elwell, Y. Sun, L.W. Oberley, T.D. Oberley, S.J. Sullivan, and R.J. Roberts Oxygen toxicity in control and H2O2-resistant Chinese hamster fibroblast cell lines Arch. Biochem. Biophys. 279 1990 249 260
170. D.R. Spitz, D.T. Adams, C.M. Sherman, and R.J. Roberts Mechanisms of cellular resistance to hydrogen peroxide, hyperoxia, and 4-hydroxy-2-nonenal toxicity: the significance of increased catalase activity in H2O2-resistant fibroblasts Arch. Biochem. Biophys. 292 1992 221 227
171. S.J. Sullivan, T.D. Oberley, R.J. Roberts, and D.R. Spitz A stable O2-resistant cell line: role of lipid peroxidation byproducts in O2-mediated injury Am. J. Physiol. 262 1992 L748 L756
172. J.D. Hayes, and L.I. McLellan Glutathione and glutathione-dependent enzymes represent a co-ordinately regulated defence against oxidative stress Free Radic. Res. 31 1999 273 300
173. L. Lusini, S.A. Tripodi, R. Rossi, F. Giannerini, D. Giustarini, M.T. del Vecchio, G. Barbanti, M. Cintorino, P. Tosi, and P. Di Simplicio Altered glutathione anti-oxidant metabolism during tumor progression in human renal-cell carcinoma Int. J. Cancer 91 2001 55 59
174. C. Sweeney, D.C. Farrow, S.M. Schwartz, D.L. Eaton, H. Checkoway, and T.L. Vaughan Glutathione S-transferase M1, T1, and P1 polymorphisms as risk factors for renal cell carcinoma: a case-control study Cancer Epidemiol. Biomarkers Prev. 9 2000 449 454
175. T. Bruning, M. Lammert, M. Kempkes, R. Thier, K. Golka, and H.M. Bolt Influence of polymorphisms of GSTM1 and GSTT1 for risk of renal cell cancer in workers with long-term high occupational exposure to trichloroethene Arch. Toxicol. 71 1997 596 599